SHL Telemedicine Ltd.
SMDCF
Get informed when a big investor buys or sells
+ FollowMarket Cap$33.6M
Close$
Share Statistics
| Market cap | $33.60 Million |
|---|---|
| Enterprise Value | $42.59 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | -83.96% |
|---|---|
| Return on Assets | -40.80% |
| Return on Invested Capital | -52.73% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.5 |
| Enterprise Value to EBIT | -1.49 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.39 |
| Debt to Equity | 0.42 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About SHL Telemedicine International Ltd
526 employees
CEO: David Arnon SHL Telemedicine Ltd., founded in 1987 and headquartered in Tel Aviv, Israel, is a leading innovator in the development and global distribution of personal telemedicine solutions, serving markets across Israel, Europe, and beyond. The co...